DeMuro, R
In clinical trials of ADHD, weight loss occurred in: 3% to 4% of adults who took Vyvanse 9% of children who took Vyvanse 0% to 1% of adults and children who took a placebo (treatment containing no active drug) After 4 weeks of treatment, the average weight loss in people who took Vyvanse was: 2.8 pounds (lb) to 4.3 lb (1.3 kilograms [kg] to 2 kg) in adults 2.7 lb to 4.8 lb (1.2 kg to 2.2 kg) in children ages 13 to 17 years 0.9 lb to 2.5 lb (0.4 kg to 1.1 kg) in children ages 6 to 12 years The amount of weight lost depended on dose, with more weight loss seen in people who took higher doses of Vyvanse
SGLT2i also play a role
"While most people who try cannabis do not go on to develop cannabis use disorder, some studies estimate that nearly 30% will," said Sanchez-Roige
Enhanced weight loss Combined with behavioural therapies and dietary interventions, Semaglutides appetite-suppressing effects can complement lifestyle changes, leading to more significant and sustained weight loss
One approach is to increase oxygen affinity of the hemoglobin molecule, an example is Oxbryta TM (Voxelotor/GBT440) (Vichinsky et al., 2019) that was recently approved by the FDA in November 2019, making this the second anti-sickling agent
